With immunotherapy trial, ‘a real paradigm shift’ in rare skin cancer – Fred Hutch News Service
Fred Hutch News Service |
With immunotherapy trial, 'a real paradigm shift' in rare skin cancer
Fred Hutch News Service Dr. Paul Nghiem of the University of Washington and Fred Hutch was a senior investigator on a trial of an immunotherapy drug in chemotherapy-resistant, metastatic Merkel cell carcinoma, a rare skin cancer. The one-year follow-up data were presented at … |
